I would wait for a capital raise before investing - actually, I have my doubts, after loosely following this company for several years, whether this mngt. team can ever bring their product to market in sufficient numbers to be a viable concern; but then biotech is more my specialty.
If you read a few prior messages, you should know that this board has been ruined by a few disgruntled John Petersen haters who are wasting their lives reliving their investment mistakes of 10-12 years ago. Axion has good battery-chemistry technology, but has failed to get it to market in any meaningful volume. It's like waiting for Gordot while watching your investment value fade into the sunset. It may happen, but the longer it takes the greater the likelihood that its technology advantage will be either eroded or leapfrogged. This is an decent speculation at these prices if you are using mad money that you can afford to lose with a smile on your face. Peter